Ranbaxy Laboratories Limited is an integrated international pharmaceuticals company. The Company is engaged in the marketing, production and distribution of pharmaceuticals products. It operates in two segments: pharmaceuticals and other business. Pharmaceuticals segment comprises manufacture and trading of formulations, active pharmaceuticals ingredients (API) and intermediate, generics, drug discovery and consumer health care products. Other business comprises rendering of financial services. The Company has manufacturing facilities in seven countries, namely India, the United States of America, Ireland, Malaysia, Nigeria, Romania and South Africa. Its major markets include the United States, India, Europe, Russia/ Commonwealth of Independent States and South Africa. The research and development activities of the Company are principally carried out at its facilities in Gurgaon, near New Delhi, India. In March 2012, the Company opened a production facility in Morocco.